A New Orleans nonprofit organization wants a federal court order that would require officials of the Louisiana State Penitentiary to grant center attorneys and a medical specialist access to death-row inmates and records at Angola.
Advocacy Center attorneys say in a civil lawsuit that prison officials have refused to allow them to pursue prisoner reports that death-row temperatures have exceeded 100 degrees.
Louisiana's health agency must save $56 million on drugs for Medicaid patients to help balance the state budget, but doesn't yet have a final plan for doing that.
A top aide to health Secretary Bruce Greenstein say the changes will take effect Oct. 1, and emergency rules will be published in September.
Legislators, pharmacy interests and others tell The Advocate they are concerned about the lack of transparency and what they call a rush to make changes that need caution to avoid damaging health care. Consumer groups worry about restricted drug access.
Mackie Shilstone isn't only New Orleans' health and fitness guru, he's a worldwide sports phenomenon. Mackie talks about working with superstar athletes — like Serena Williams, whom he recently helped recapture Wimbledon — and his own will to win.
The Louisiana Department of Health and Hospitals says four new cases of West Nile virus bring this year's total to 14.
It says the new cases include the year's third nervous system infection — the infection's most dangerous form. That patient is in St. Tammany Parish; earlier neuroinvasive cases were reported in Rapides and Vernon parishes.
The other new cases were in Bossier and East and West Baton Rouge parishes. They include one patient with flu-like West Nile fever and two people without symptoms, found in blood donor screening.
High-tech gadgets, like smartphones, keep us connected at all hours and are making it more difficult to get a good night's sleep. But several new smartphone apps claim to help users sleep better. New York Times health and fitness reporter Anahad O'Connor explains the science behind apps.
The Food and Drug Administration has given the first OK for a drug to prevent HIV infection.
The daily pill Truvada, made by Gilead Sciences, combines two medicines that inhibit the reproduction of HIV. It's been a mainstay in the treatment of HIV/AIDS for years, and as of today is an approved option for reducing the risk of HIV infection for people at high risk.